Circulating tumour cells as surrogate biomarkers in castration-resistant prostate cancer trials
- PMID: 21871707
- DOI: 10.1016/j.eururo.2011.08.024
Circulating tumour cells as surrogate biomarkers in castration-resistant prostate cancer trials
Comment on
-
TMPRSS2-ERG status in circulating tumor cells as a predictive biomarker of sensitivity in castration-resistant prostate cancer patients treated with abiraterone acetate.Eur Urol. 2011 Nov;60(5):897-904. doi: 10.1016/j.eururo.2011.07.011. Epub 2011 Jul 14. Eur Urol. 2011. PMID: 21802835 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
